Natera Inc., a leader in genetic testing and diagnostics, has announced significant growth in its financial results for the second quarter of 2024. The company's revenue increased by 12% from Q1 2024 and an impressive 58% compared to the same period last year. This growth has prompted Natera to raise its full-year revenue guidance to approximately $1.5 billion, with an expected gross margin of 55%.
Exclusive Access: Unlock Premium, Confidential Insights
Unlock This Exclusive Content—Subscribe Instantly!
Login if you have purchased
